Celldex Therapeutics, Inc. (CLDX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.81B |
| Enterprise Value | 1.78B |
| P/E Ratio | -9.26 |
| PEG Ratio | 0.27 |
| Price/Sales Ratio | 23,989.49 |
| Price/Book Ratio | 4.4 |
| Enterprise/Revenue | 23,609.58 |
| Enterprise/EBITDA | -8.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2,683.86 |
| Operating Margin | -2,909.48 |
| Return On Assets | -0.38 |
| Return On Equity | -0.52 |
| Revenue | 1.5M |
| Revenue/Share | 0 |
| Gross Profit | 1.5M |
| EBITDA | -255.42M |
| Net Income | -258.8M |
| Diluted EPS | -3.9 |
| Total Cash | 717.59M |
| Total Cash/Share | 9.22 |
| Total Debt | 4.9M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 11.82 |
| Book Value Per Share | 9.18 |
| 52-Week Change | 79.79 |
| 52-Week High | 45.14 |
| 52-Week Low | 21.34 |
| Moving Average 50 Days | 37.53 |
| Moving Average 200 Days | 30.77 |
| Average Volume | 1.05M |
| Shares Outstanding | 66.54M |
| % Held by Institutions | 128.62 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 11, 2019 |